196 related articles for article (PubMed ID: 25343542)
1. Fluorouracil, leucovorin and irinotecan combined with intra-arterial hepatic infusion of drug-eluting beads preloaded with irinotecan in unresectable colorectal liver metastases: side effects and results of a concomitant treatment schedule. Clinical investigation.
Kekez D; Badzek S; Prejac J; Gorsic I; Golem H; Librenjak N; Perkov D; Smiljanic R; Plestina S
Tumori; 2014; 100(5):499-503. PubMed ID: 25343542
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
Bhutiani N; Akinwande O; Martin RC
World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
[TBL] [Abstract][Full Text] [Related]
3. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
Martin RC; Joshi J; Robbins K; Tomalty D; Bosnjakovik P; Derner M; Padr R; Rocek M; Scupchenko A; Tatum C
Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
[TBL] [Abstract][Full Text] [Related]
4. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
[TBL] [Abstract][Full Text] [Related]
6. Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization.
Scevola G; Loreni G; Rastelli M; Sposato S; Ramponi S; Miele V
Med Oncol; 2017 Mar; 34(3):37. PubMed ID: 28160267
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.
Fiorentini G; Aliberti C; Tilli M; Mulazzani L; Graziano F; Giordani P; Mambrini A; Montagnani F; Alessandroni P; Catalano V; Coschiera P
Anticancer Res; 2012 Apr; 32(4):1387-95. PubMed ID: 22493375
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).
de Baere T; Tselikas L; Boige V; Ducreux M; Malka D; Goéré D; Benahim E; Deschamps F
Bull Cancer; 2017 May; 104(5):402-406. PubMed ID: 27993355
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
Richardson AJ; Laurence JM; Lam VW
J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.
Martin RC; Scoggins CR; Tomalty D; Schreeder M; Metzger T; Tatum C; Sharma V
J Gastrointest Surg; 2012 Aug; 16(8):1531-8. PubMed ID: 22528576
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
Yamaguchi T; Matsumoto H; Yasutome M; Mori T; Takahashi K
Cancer Chemother Pharmacol; 2011 Mar; 67(3):629-35. PubMed ID: 20495917
[TBL] [Abstract][Full Text] [Related]
13. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
Shimonov M; Hayat H; Chaitchik S; Brener J; Schachter P; Czerniak A
Chemotherapy; 2005 May; 51(2-3):111-5. PubMed ID: 15886466
[TBL] [Abstract][Full Text] [Related]
14. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
15. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
Akinwande O; Scoggins C; Martin RC
Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases.
Min BS; Kim NK; Ahn JB; Roh JK; Kim KS; Choi JS; Cha SH; Kim H
Onkologie; 2007 Dec; 30(12):637-43. PubMed ID: 18063876
[TBL] [Abstract][Full Text] [Related]
17. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
18. Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.
Teufel A; Steinmann S; Siebler J; Zanke C; Hohl H; Adami B; Schroeder M; Klein O; Höhler T; Galle PR; Heike M; Moehler M
BMC Cancer; 2004 Jul; 4():38. PubMed ID: 15265233
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
Pernot S; Pellerin O; Artru P; Montérymard C; Smith D; Raoul JL; De La Fouchardière C; Dahan L; Guimbaud R; Sefrioui D; Jouve JL; Lepage C; Tougeron D; Taieb J;
Br J Cancer; 2020 Aug; 123(4):518-524. PubMed ID: 32507854
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]